Specialty labs invest heavily in the ordering physician relationship. Sales teams, medical affairs, clinical education programs, client services coverage, etc. All of it oriented toward a single goal: keeping the ordering physician sending patients to your lab.
What most specialty labs underinvest in is the one thing that determines whether those patients' orders actually produce results: the collection infrastructure between the physician's order and the specimen arriving at the lab.
The ordering physician relationship isn't just a commercial relationship. It's an infrastructure relationship — and the labs that understand this are building a competitive position that's genuinely difficult to displace.
When an ordering physician sends a patient to complete a specialty lab draw, they're making an assumption they can't verify: that the collection infrastructure exists in that patient's market to complete the test correctly.
They don't know whether the nearest qualified draw site is two miles from the patient's home or 45 miles away. They don't know whether the draw site has been trained on their specific test's kit requirements. They don't know whether the collection documentation is going to be completed correctly.
They order the test and wait for the result.
When the result doesn't come back, their conclusion is almost always wrong — because the failure happened upstream of the lab, at a draw site the physician didn't select and the lab didn't fully control. But the physician doesn't see the draw site failure. They see a lab that didn't deliver a result.
The ordering physician doesn't see the draw site failure. They see a lab that didn't deliver a result. That's the relationship risk most specialty labs are underestimating.
A single missed result rarely ends an ordering physician relationship. It generates a conversation, an explanation, and a promise that it won't happen again.
A pattern of missed results — particularly from the same geographies or the same patient populations — erodes the relationship without a clear inflection point. The physician doesn't call to complain. They redirect. Over several months, volume from that physician to your lab decreases. The cause doesn't show up in the CRM as a collection infrastructure problem. It shows up as physician churn.
The labs tracking this data consistently find the same pattern: ordering physician attrition correlates more strongly with collection completion rates in the physician's patient geography than with almost any other commercial variable.
The retention problem is a collection infrastructure problem in disguise.
The specialty labs building the most durable ordering physician relationships share a specific approach to collection infrastructure: they've made collection visibility part of the service model.
Before a new ordering physician relationship begins, these labs map their collection network coverage against the physician's patient geography. They identify the markets where coverage is strong and the markets where gaps exist. They surface that information proactively — because a physician who knows about a coverage gap before their patient encounters it can work around it. A physician who discovers the gap when a patient misses a draw develops a different impression of the lab entirely.
The most sophisticated labs in this space report collection completion rates back to their ordering physician clients — by geography, by test category, and over time. This transforms the physician from a passive observer of outcomes into an informed partner in the collection process. It also creates an accountability structure that most physician-lab relationships don't have: the physician can see whether their patients are completing the draws, and the lab can see which physician's patient geographies have access gaps that are affecting results.
When a draw site partner in a key market goes dark — loses a phlebotomist, changes terms, exits the geography — the labs that maintain the physician relationship best are the ones that alert the affected ordering physicians before a gap produces a missed result. That proactive communication converts a potential failure into a demonstration of operational competence.
The framing most specialty labs use for collection infrastructure is operational: a cost to manage, a problem to solve, a logistics challenge to navigate.
The labs winning the ordering physician relationship have reframed it as clinical: a service capability that enables consistent result delivery, that supports treatment decisions, and that positions the lab as a reliable clinical partner rather than a vendor to evaluate annually.
An ordering physician who trusts that their patients will get results — regardless of where those patients live, what their transportation situation is, or which draw site they end up using — doesn't shop for alternatives. They don't respond to competitor outreach. They become a long-term relationship that compounds in value.
That trust is built one completed draw at a time.
The collection infrastructure required to support a durable ordering physician relationship has three components:
Geographic depth in the markets where the physician's patients live — not just in major metro areas, but in the rural and semi-rural communities that often represent a meaningful share of a specialty physician's patient population.
Specialty training across the test portfolio — draw site partners who are trained on the specific collection requirements of the tests the physician orders, not just general phlebotomy competency.
Visibility and reporting infrastructure — the data systems that let the lab track completion rates by geography and communicate proactively with ordering physician clients when gaps emerge.
Most specialty labs have the first two components partially. Almost none have the third built out systematically.
MOMS provides the network infrastructure for all three — geographic reach into markets that most collection networks don't serve well, specialty training requirements built into MAP onboarding, and the data layer that makes completion rate visibility possible at scale.
The ordering physician relationship starts at the draw site. The labs that invest in that connection are building something their competitors can't easily replicate.